<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="the PMC Open Access Subset for unrestricted research re-use and" exact="secondary" post="analysis in any form or by any means with"/>
 <result pre="Nanomaterials COVID-19 Nano-vaccines Nanodrugs Introduction COVID-19 is caused by severe" exact="acute" post="respiratory syndrome coronavirus 2 (SARS-CoV-2), a lethal beta-type virus"/>
 <result pre="COVID-19 Nano-vaccines Nanodrugs Introduction COVID-19 is caused by severe acute" exact="respiratory" post="syndrome coronavirus 2 (SARS-CoV-2), a lethal beta-type virus belonging"/>
 <result pre="Nano-vaccines Nanodrugs Introduction COVID-19 is caused by severe acute respiratory" exact="syndrome" post="coronavirus 2 (SARS-CoV-2), a lethal beta-type virus belonging to"/>
 <result pre="related group of viruses known as coronaviruses, leading to serious" exact="infections" post="in the respiratory tract of humans (Fan et al."/>
 <result pre="viruses known as coronaviruses, leading to serious infections in the" exact="respiratory" post="tract of humans (Fan et al. 2019; Sivakumar 2020;"/>
 <result pre="as SARS-CoV, HCoV NL63, HKU1, MERS-CoV, and SARS-CoV-2 causing COVID-19" exact="disease" post="(Su et al. 2016; Zhu et al. 2020). The"/>
 <result pre="Latin corona meaning crown, the name corresponds to their unique" exact="morphology" post="due to the presence of viral spike proteins (Chafekar"/>
 <result pre="corresponds to their unique morphology due to the presence of" exact="viral" post="spike proteins (Chafekar 2012; Lopez 2007). Coronaviruses have large"/>
 <result pre="by the World Health Organization (WHO) (Angel-Korman et al. 2020)." exact="Severity of" post="COVID-19 Unlike SARS-CoV, COVID-19 transmission takes place during the"/>
 <result pre="and carrying on with their common activities, facilitating spread of" exact="infection" post="(Liu et al. 2020). Direct contact with infected individuals"/>
 <result pre="individuals at risk include elderly (&amp;gt;â€‰60Â years old); cardiac, diabetic," exact="chronic" post="respiratory, cancer patients, and individuals in long-term care facilities"/>
 <result pre="risk include elderly (&amp;gt;â€‰60Â years old); cardiac, diabetic, chronic respiratory," exact="cancer" post="patients, and individuals in long-term care facilities (Kabir et"/>
 <result pre="individuals in long-term care facilities (Kabir et al. 2020). SARS-CoV-2" exact="infection" post="and replication The virus relies on the ACE2 receptor"/>
 <result pre="not only for host cell entry but also for subsequent" exact="viral" post="replication (Zhang et al. 2020b). High viral loads have"/>
 <result pre="also for subsequent viral replication (Zhang et al. 2020b). High" exact="viral" post="loads have been observed in the lower respiratory tract,"/>
 <result pre="al. 2020b). High viral loads have been observed in the" exact="lower" post="respiratory tract, proposing that the virus might have a"/>
 <result pre="2020b). High viral loads have been observed in the lower" exact="respiratory" post="tract, proposing that the virus might have a higher"/>
 <result pre="might have a higher affinity for the epithelium of the" exact="lower" post="respiratory tract and indicating a need for repeat testing"/>
 <result pre="have a higher affinity for the epithelium of the lower" exact="respiratory" post="tract and indicating a need for repeat testing of"/>
 <result pre="tract and indicating a need for repeat testing of the" exact="upper" post="or lower respiratory tract samples in the setting of"/>
 <result pre="indicating a need for repeat testing of the upper or" exact="lower" post="respiratory tract samples in the setting of an initial"/>
 <result pre="a need for repeat testing of the upper or lower" exact="respiratory" post="tract samples in the setting of an initial negative"/>
 <result pre="et al. 2020a). SARS-CoV-2 is known to cause a delayed" exact="type I" post="interferon response during the initial phases of infection (Frieman"/>
 <result pre="delayed type I interferon response during the initial phases of" exact="infection" post="(Frieman and Baric 2008). Infection and viral replication lead"/>
 <result pre="during the initial phases of infection (Frieman and Baric 2008)." exact="Infection" post="and viral replication lead to activation of neutrophils, macrophages,"/>
 <result pre="initial phases of infection (Frieman and Baric 2008). Infection and" exact="viral" post="replication lead to activation of neutrophils, macrophages, and monocytes"/>
 <result pre="patterns by endosomal RNA receptors, TLR7 and TLR3, and the" exact="cytosolic" post="RNA sensor, RIG-I/MDA5 (Kell and Gale Jr 2015; Poeck"/>
 <result pre="or confirmed case (https://www.cdc.gov/coronavirus/2019-ncov/community/correction-detention/guidance-correctional-detention.html). History of patients infected with coronavirus" exact="disease" post="2019 (COVID-19) can include international travel to where COVID-19"/>
 <result pre="through many laboratory tests. Specific laboratory tests include serology for" exact="viral" post="antigen, molecular testing, and viral culture (Kabir et al."/>
 <result pre="laboratory tests include serology for viral antigen, molecular testing, and" exact="viral" post="culture (Kabir et al. 2020; Storch 2000). All these"/>
 <result pre="Storch 2000). All these tests can be used to confirm" exact="infection" post="with coronavirus. Non-specific laboratory findings in COVID-19 include lymphocytopenia,"/>
 <result pre="lactate dehydrogenase, interleukin-4, and procalcitonin (Lippi and Plebani 2020). The" exact="chest" post="x-ray remarks of a suspected coronavirus case can be"/>
 <result pre="remarks of a suspected coronavirus case can be similar to" exact="pneumonia" post="(Jacobi et al. 2020). Severe cases of COVID-19 progressing"/>
 <result pre="case can be similar to pneumonia (Jacobi et al. 2020)." exact="Severe" post="cases of COVID-19 progressing to acute respiratory distress syndrome"/>
 <result pre="(Jacobi et al. 2020). Severe cases of COVID-19 progressing to" exact="acute" post="respiratory distress syndrome (ARDS) can show a typical â€œwhite-outâ€�"/>
 <result pre="et al. 2020). Severe cases of COVID-19 progressing to acute" exact="respiratory" post="distress syndrome (ARDS) can show a typical â€œwhite-outâ€� on"/>
 <result pre="2020). Severe cases of COVID-19 progressing to acute respiratory distress" exact="syndrome" post="(ARDS) can show a typical â€œwhite-outâ€� on chest x-ray"/>
 <result pre="respiratory distress syndrome (ARDS) can show a typical â€œwhite-outâ€� on" exact="chest" post="x-ray (Venugopal et al. 2020). There are no specific"/>
 <result pre="2020). There are no specific echocardiography/ultrasound findings associated with coronavirus" exact="infection" post="(Zheng et al. 2020). Non-specific echocardiographic findings can include"/>
 <result pre="Non-specific echocardiographic findings can include left ventricular systolic dysfunction and" exact="pericardial effusion" post="(PÃ©rez-Casares et al. 2017). Chest CT scan findings in"/>
 <result pre="CT scan findings in patients infected with coronavirus can include" exact="unilateral" post="or bilateral pneumonia, mottling and ground glass opacity, focal"/>
 <result pre="findings in patients infected with coronavirus can include unilateral or" exact="bilateral" post="pneumonia, mottling and ground glass opacity, focal or multifocal"/>
 <result pre="include unilateral or bilateral pneumonia, mottling and ground glass opacity," exact="focal" post="or multifocal opacities, consolidation, and septal thickening with sub-pleural"/>
 <result pre="or multifocal opacities, consolidation, and septal thickening with sub-pleural and" exact="lower" post="lobe involvement more likely (Wu et al. 2020). COVID-19"/>
 <result pre="(Wu et al. 2020). COVID-19 current medications Treatment of coronavirus" exact="infection" post="includes supportive measures and symptomatic management. No specific treatment"/>
 <result pre="current medications Treatment of coronavirus infection includes supportive measures and" exact="symptomatic" post="management. No specific treatment is available. Given the emergence"/>
 <result pre="mg/day) were given as a combined regimen if severe community-acquired" exact="pneumonia" post="was diagnosed (Chen et al. 2011). Oxygen support (e.g.,"/>
 <result pre="avoiding virus exposure is the best way to prevent the" exact="infection" post="(Organization 2020). Nanomaterials as promising nano-vaccines and nano-drug Nanotechnology"/>
 <result pre="NPs by zone of inhibition (ZOI) method against E. coli" exact="bacterial" post="cells, (b) suggested reaction mechanism of some nanoparticles (Ag"/>
 <result pre="some nanoparticles (Ag and Au NPs) and drugs nanocarriers against" exact="bacterial" post="cells ((I): NPs are firstly-interact with the external part"/>
 <result pre="nanocarriers against bacterial cells ((I): NPs are firstly-interact with the" exact="external" post="part of the pathogenic bacteria and change their membrane"/>
 <result pre="bacteria and change their membrane composition, and then they easily-enter" exact="bacterial" post="cells because of their small nano-size; (II) NPs are"/>
 <result pre="because of their small nano-size; (II) NPs are quickly-diffused across" exact="bacterial" post="cells and interacted with the main bacterial organelles and"/>
 <result pre="are quickly-diffused across bacterial cells and interacted with the main" exact="bacterial" post="organelles and bio-molecules and increased cellular toxicity, loss of"/>
 <result pre="stability, and finally genotoxicity; (III) NPs generated active ROS inside" exact="bacterial" post="cells and initiated bacterial cell disruption; and (VI) NPs"/>
 <result pre="(III) NPs generated active ROS inside bacterial cells and initiated" exact="bacterial" post="cell disruption; and (VI) NPs have alternated the cellular"/>
 <result pre="serve as a vehicle to deliver their ions to the" exact="bacterial" post="cytoplasm leading to a reduction in the proton motive"/>
 <result pre="in the proton motive force (PMF) which might decrease the" exact="bacterial" post="cell pH to less than 3.5, and promoting the"/>
 <result pre="wall and high cell count, and (d) malformed and distorted" exact="bacterial" post="cell (E. coli) following the treatment of NPs suggesting"/>
 <result pre="of NPs suggesting the usage of NPs in fighting the" exact="secondary" post="bacterial infection associated with viral diseases The antimicrobial activity"/>
 <result pre="NPs suggesting the usage of NPs in fighting the secondary" exact="bacterial infection" post="associated with viral diseases The antimicrobial activity results of"/>
 <result pre="suggesting the usage of NPs in fighting the secondary bacterial" exact="infection" post="associated with viral diseases The antimicrobial activity results of"/>
 <result pre="of NPs in fighting the secondary bacterial infection associated with" exact="viral" post="diseases The antimicrobial activity results of some green synthesized"/>
 <result pre="Immune systemâ€&quot;stimulating nano-vaccines could be easily-assembled through either encapsulation of" exact="viral" post="parts within NMs or via decoration (covalent functionalization) on"/>
 <result pre="with very small concentrations could be employed to control the" exact="disease" post="via surfacesâ€™ coating and disinfection at hospitals and public"/>
 <result pre="recombinant technologies are considered on the most promising nano-vaccines against" exact="respiratory" post="viruses (Scheerlinck and Greenwood 2008; Schneider-Ohrum and Ross 2012)."/>
 <result pre="lipid nanoparticles carrying SARS-CoV and MERS-CoV spike proteins without any" exact="viral" post="proteins which effectively-induced antibody responses in mice (Coleman et"/>
 <result pre="al. tested vaccines based on virus-like particles (VLPs) similar in" exact="morphology" post="and size to the wild SARS-CoV, comprising SARS spike"/>
 <result pre="2011). Upon treatment, mice protection from death, reducing the lung" exact="infection" post="and antibodies against the virus, were achieved. Another study"/>
 <result pre="Indeed, NMs can be employed as either nano-vaccines to prevent" exact="viral infection" post="and to control its spread or as nano-drugs for"/>
 <result pre="NMs can be employed as either nano-vaccines to prevent viral" exact="infection" post="and to control its spread or as nano-drugs for"/>
 <result pre="electrostatic attractions or when NMs enter the host cell through" exact="transient" post="pores in its cell membrane to fight the virus"/>
 <result pre="of transcription factors by receptor signaling as a response of" exact="viral" post="RNA and either the formation of pro-inflammatory cytokines (IL-1B)"/>
 <result pre="2020; Ojo et al. 2016). Moreover, serious complications such as" exact="heart" post="attacks and strokes can be also suppressed (Elegbede et"/>
 <result pre="be devoted for investigating the efficiency of these nanomaterials against" exact="viral" post="samples as a step towards cure development. Importantly, with"/>
 <result pre="incubation with the nucleocapsid protein of the NL63 coronavirus ChanJF-WYuanSKokK-HTosKK-WChuHYangJXingFLiuJYipCC-YPoonRW-SA" exact="familial" post="cluster of pneumonia associated with the 2019 novel coronavirus"/>
 <result pre="nucleocapsid protein of the NL63 coronavirus ChanJF-WYuanSKokK-HTosKK-WChuHYangJXingFLiuJYipCC-YPoonRW-SA familial cluster of" exact="pneumonia" post="associated with the 2019 novel coronavirus indicating person-to-person transmission:"/>
 <result pre="Corticosteroids for pneumonia. Cochrane database of systematic reviews, Corticosteroids for" exact="pneumonia" post="Choi J, Kim M-G, Oh Y-K, Kim YB (2017)"/>
 <result pre="M-G, Oh Y-K, Kim YB (2017) Progress of Middle East" exact="respiratory" post="syndrome coronavirus vaccines: a patent review. Expert Opin Ther"/>
 <result pre="Oh Y-K, Kim YB (2017) Progress of Middle East respiratory" exact="syndrome" post="coronavirus vaccines: a patent review. Expert Opin Ther Pat"/>
 <result pre="CfD, Prevention (2014) Influenza antiviral medications: summary for clinicians CurleyGFLaffyJGZhangHSlutskyASNoninvasive" exact="respiratory" post="support for acute respiratory failureâ€&quot;high flow nasal cannula oxygen"/>
 <result pre="Influenza antiviral medications: summary for clinicians CurleyGFLaffyJGZhangHSlutskyASNoninvasive respiratory support for" exact="acute" post="respiratory failureâ€&quot;high flow nasal cannula oxygen or non-invasive ventilation?J"/>
 <result pre="antiviral medications: summary for clinicians CurleyGFLaffyJGZhangHSlutskyASNoninvasive respiratory support for acute" exact="respiratory" post="failureâ€&quot;high flow nasal cannula oxygen or non-invasive ventilation?J Thorac"/>
 <result pre="non-invasive ventilation?J Thorac Dis20157109226380720 DhakalSRenukaradhyaGJNanoparticle-based vaccine development and evaluation against" exact="viral" post="infections in pigsVet Res2019509010.1186/s13567-019-0712-531694705 El-BatalAIMosallamFMEl-SayyadGSSynthesis of metallic silver nanoparticles"/>
 <result pre="ventilation?J Thorac Dis20157109226380720 DhakalSRenukaradhyaGJNanoparticle-based vaccine development and evaluation against viral" exact="infections" post="in pigsVet Res2019509010.1186/s13567-019-0712-531694705 El-BatalAIMosallamFMEl-SayyadGSSynthesis of metallic silver nanoparticles by"/>
 <result pre="replication and pathogenesis, coronaviruses. Springer, pp 1â€&quot;23 FriemanMBaricRMechanisms of severe" exact="acute" post="respiratory syndrome pathogenesis and innate immunomodulationMicrobiol Mol Biol Rev20087267268510.1128/MMBR.00015-0819052324"/>
 <result pre="and pathogenesis, coronaviruses. Springer, pp 1â€&quot;23 FriemanMBaricRMechanisms of severe acute" exact="respiratory" post="syndrome pathogenesis and innate immunomodulationMicrobiol Mol Biol Rev20087267268510.1128/MMBR.00015-0819052324 GoldsmithCSTattiKMKsiazekTGRollinPEComerJALeeWWRotaPABankampBBelliniWJZakiSRUltrastructural"/>
 <result pre="pathogenesis, coronaviruses. Springer, pp 1â€&quot;23 FriemanMBaricRMechanisms of severe acute respiratory" exact="syndrome" post="pathogenesis and innate immunomodulationMicrobiol Mol Biol Rev20087267268510.1128/MMBR.00015-0819052324 GoldsmithCSTattiKMKsiazekTGRollinPEComerJALeeWWRotaPABankampBBelliniWJZakiSRUltrastructural characterization"/>
 <result pre="induced by the pathogenic H5N1 influenza virusInt J Nanomedicine20201566167410.2147/IJN.S22166732099358 JacobiAChungMBernheimAEberCPortable" exact="chest" post="X-ray in coronavirus disease-19 (COVID-19): a pictorial reviewClin Imaging202064354210.1016/j.clinimag.2020.04.00132302927"/>
 <result pre="disease-19 (COVID-19): a pictorial reviewClin Imaging202064354210.1016/j.clinimag.2020.04.00132302927 JansenRRWieringaJKoekkoekSMVisserCEPajkrtDMolenkampRde JongMDSchinkelJFrequent detection of" exact="respiratory" post="viruses without symptoms: toward defining clinically relevant cutoff valuesJ"/>
 <result pre="Laboratory abnormalities in patients with COVID-2019 infection. 20200198 LiuYVMassareMJBarnardDLKortTNathanMWangLSmithGChimeric severe" exact="acute" post="respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix"/>
 <result pre="abnormalities in patients with COVID-2019 infection. 20200198 LiuYVMassareMJBarnardDLKortTNathanMWangLSmithGChimeric severe acute" exact="respiratory" post="syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1"/>
 <result pre="in patients with COVID-2019 infection. 20200198 LiuYVMassareMJBarnardDLKortTNathanMWangLSmithGChimeric severe acute respiratory" exact="syndrome" post="coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently"/>
 <result pre="F, Liu L, Zhang Z (2020) Community transmission of severe" exact="acute" post="respiratory syndrome coronavirus 2, Shenzhen, China, 2020. Emerg Infect"/>
 <result pre="Liu L, Zhang Z (2020) Community transmission of severe acute" exact="respiratory" post="syndrome coronavirus 2, Shenzhen, China, 2020. Emerg Infect Dis"/>
 <result pre="L, Zhang Z (2020) Community transmission of severe acute respiratory" exact="syndrome" post="coronavirus 2, Shenzhen, China, 2020. Emerg Infect Dis 26"/>
 <result pre="in subcellular trafficking and virus assembly. Arizona State University McCullohRJKosterMChapinKRespiratory" exact="viral" post="testing: new frontiers in diagnostics and implications for antimicrobial"/>
 <result pre="antimicrobial stewardshipVirulence201341210.4161/viru.2278823314568 MehrabiMDounighiNMMohammadiMMasoudiANanoparticles and vaccine developmentPharm Nanotechnol2020862110.2174/221173850766619102416204231647394 MitsdoerfferMLeeYJÃ¤gerAKimH-JKornTKollsJKCantorHBettelliEKuchrooVKProinflammatory T helper" exact="type 17" post="cells are effective B-cell helpersProc Natl Acad Sci2010107142921429710.1073/pnas.100923410720660725 MohamedHEAAfridiSKhalilATAliMZohraTAkhtarRIkramAShinwariZKMaazaMPromising"/>
 <result pre="and therapeutic properties of green nanoceriaNanomedicine20201546748810.2217/nnm-2019-036832063095 NikitinaELarionovaIChoinzonovEKzhyshkowskaJMonocytes and macrophages as" exact="viral" post="targets and reservoirsInt J Mol Sci201819282110.3390/ijms19092821 OjoSALateefAAzeezMAOladejoSMAkinwaleASAsafaTBYekeenTAAkinboroAOladipoICGueguim-KanaEBBiomedical and catalytic"/>
 <result pre="anti-coagulant and thrombolytic activitiesIEEE Trans Nanobioscience20161543344210.1109/TNB.2016.255916127164598 Organization WH (2020) Coronavirus" exact="disease" post="2019 (COVID-19): situation report, 72 PandaPKArulMNPatelPVermaSKLuoWRubahnH-GMishraYKSuarMAhujaRStructure-based drug designing and"/>
 <result pre="adenovirus 5 vaccines induce specific antibodies against the Middle East" exact="respiratory" post="syndrome coronavirus (MERS-CoV). Am Assoc Immnol PÃ©rez-CasaresACesarSBrunet-GarciaLSanchez-de-ToledoJEchocardiographic evaluation of"/>
 <result pre="5 vaccines induce specific antibodies against the Middle East respiratory" exact="syndrome" post="coronavirus (MERS-CoV). Am Assoc Immnol PÃ©rez-CasaresACesarSBrunet-GarciaLSanchez-de-ToledoJEchocardiographic evaluation of pericardial"/>
 <result pre="respiratory syndrome coronavirus (MERS-CoV). Am Assoc Immnol PÃ©rez-CasaresACesarSBrunet-GarciaLSanchez-de-ToledoJEchocardiographic evaluation of" exact="pericardial effusion" post="and cardiac tamponadeFront Pediatr201757910.3389/fped.2017.0007928484689 PoeckHBscheiderMGrossOFingerKRothSRebsamenMHannesschlÃ¤gerNSchleeMRothenfusserSBarchetWRecognition of RNA virus by"/>
 <result pre="Dang VQ (2020) Silver nanoparticles as potential antiviral agents against" exact="African" post="swine fever virus. Materials Research Express Venugopal VK, Mahajan"/>
 <result pre="penetration by monolayer-protected nanoparticlesNat Mater2008758859510.1038/nmat220218500347 VosLMBruningAHReitsmaJBSchuurmanRRiezebos-BrilmanAHoepelmanAIOosterheertJJRapid molecular tests for influenza," exact="respiratory" post="syncytial virus, and other respiratory viruses: a systematic review"/>
 <result pre="VosLMBruningAHReitsmaJBSchuurmanRRiezebos-BrilmanAHoepelmanAIOosterheertJJRapid molecular tests for influenza, respiratory syncytial virus, and other" exact="respiratory" post="viruses: a systematic review of diagnostic accuracy and clinical"/>
 <result pre="activitiesJ Clust Sci20203136738910.1007/s10876-019-01651-3 WuJWuXZengWGuoDFangZChenLHuangHLiCChest CT findings in patients with coronavirus" exact="disease" post="2019 and its relationship with clinical featuresInvestig Radiol20205525726110.1097/RLI.000000000000067032091414 Xu"/>
 <result pre="mechanisms and potential therapeutic targetIntensive Care Med20204658659010.1007/s00134-020-05985-932125455 ZhengY-YMaY-TZhangJ-YXieXCOVID-19 and the" exact="cardiovascular" post="systemNat Rev Cardiol20201725926010.1038/s41569-020-0360-532139904 ZhouPYangXLWangXGHuBZhangLZhangWSiHRZhuYLiBHuangCLChenHDChenJLuoYGuoHJiangRDLiuMQChenYShenXRWangXZhengXSZhaoKChenQJDengFLiuLLYanBZhanFXWangYYXiaoGFShiZLA pneumonia outbreak associated with a"/>
 <result pre="Care Med20204658659010.1007/s00134-020-05985-932125455 ZhengY-YMaY-TZhangJ-YXieXCOVID-19 and the cardiovascular systemNat Rev Cardiol20201725926010.1038/s41569-020-0360-532139904 ZhouPYangXLWangXGHuBZhangLZhangWSiHRZhuYLiBHuangCLChenHDChenJLuoYGuoHJiangRDLiuMQChenYShenXRWangXZhengXSZhaoKChenQJDengFLiuLLYanBZhanFXWangYYXiaoGFShiZLA" exact="pneumonia" post="outbreak associated with a new coronavirus of probable bat"/>
 <result pre="investigating and research team. A novel coronavirus from patients with" exact="pneumonia" post="in China, 2019N Engl J Med202038272773310.1056/NEJMoa200101731978945"/>
</results>
